Advertisement
U.S. Markets closed

Avenue Therapeutics, Inc. (ATXI)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Visitors trend2W10W9M
2.0000-0.1100 (-5.21%)
At close: 04:00PM EDT
2.0101 +0.01 (+0.50%)
After hours: 07:51PM EDT
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
0
0
0
0
0
Operating Expense
5,045
14,540
8,043
3,738
5,213
Operating Income
-5,045
-14,540
-8,043
-3,738
-5,213
Net Non Operating Interest Income Expense
5
-206
-1,140
7
62
Other Income Expense
4,666
4,258
5,580
-
-
Pretax Income
-5,040
-10,488
-3,603
-3,731
-5,151
Net Income Common Stockholders
-5,040
-10,377
-3,552
-3,731
-5,151
Diluted NI Available to Com Stockholders
-5,040
-10,377
-3,552
-3,731
-5,151
Basic EPS
-2.62
-73.50
-122.25
-246.75
-348.75
Diluted EPS
-2.62
-73.50
-122.25
-246.75
-348.75
Basic Average Shares
3,251
141.221
29.135
15.108
14.672
Diluted Average Shares
3,251
141.221
29.135
15.108
14.672
Total Operating Income as Reported
-5,045
-14,540
-8,043
-3,738
-5,213
Total Expenses
5,045
14,540
8,043
3,738
5,213
Net Income from Continuing & Discontinued Operation
-5,040
-10,377
-3,552
-3,731
-5,151
Normalized Income
-5,040
-14,635
-9,132
-3,731
-5,151
Interest Income
5
126
20
7
62
Interest Expense
0
332
1,160
0
-
Net Interest Income
5
-206
-1,140
7
62
EBIT
-5,045
-10,156
-2,443
-3,731
-5,213
EBITDA
-5,045
-10,156
-2,443
-3,731
-5,213
Net Income from Continuing Operation Net Minority Interest
-5,040
-10,377
-3,552
-3,731
-5,151
Total Unusual Items Excluding Goodwill
4,666
4,258
5,580
-
-
Total Unusual Items
4,666
4,258
5,580
-
-
Normalized EBITDA
-5,045
-14,414
-8,023
-3,731
-5,213
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0